Evolus, Inc. (0K16.L)

USD 14.58

(0.16%)

Eps Summary of Evolus, Inc.

  • Evolus, Inc.'s latest annual eps in 2023 was -1.08 USD , up 18.8% from previous year.
  • Evolus, Inc.'s latest quarterly eps in 2024 Q2 was -0.18 USD , up 18.18% from previous quarter.
  • Evolus, Inc. reported an annual eps of -1.33 USD in 2022, down -41.49% from previous year.
  • Evolus, Inc. reported an annual eps of -0.94 USD in 2021, up 80.54% from previous year.
  • Evolus, Inc. reported a quarterly eps of -0.18 USD for 2024 Q2, up 18.18% from previous quarter.
  • Evolus, Inc. reported a quarterly eps of N/A for 2023 FY, up 18.8% from previous quarter.

Annual Eps Chart of Evolus, Inc. (2023 - 2015)

Historical Annual Eps of Evolus, Inc. (2023 - 2015)

Year Eps Eps Growth
2023 -1.08 USD 18.8%
2022 -1.33 USD -41.49%
2021 -0.94 USD 80.54%
2020 -4.83 USD -51.41%
2019 -3.19 USD -66.15%
2018 -1.92 USD -910.53%
2017 -0.19 USD 82.41%
2016 -1.08 USD 35.33%
2015 -1.67 USD 0.0%

Peer Eps Comparison of Evolus, Inc.

Name Eps Eps Difference
Thermo Fisher Scientific Inc. 15.53 USD 106.954%
Agios Pharmaceuticals, Inc. -6.33 USD 82.938%
Atara Biotherapeutics, Inc. -65.18 USD 98.343%
Cara Therapeutics, Inc. -2.19 USD 50.685%
uniQure N.V. -6.47 USD 83.308%
Amicus Therapeutics, Inc. -0.51 USD -111.765%
bluebird bio, Inc. -1.93 USD 44.041%
Imunon, Inc. -2.16 USD 50.0%
Dynavax Technologies Corporation -0.05 USD -2077.419%
Editas Medicine, Inc. -2.02 USD 46.535%
Illumina, Inc. -7.35 USD 85.306%
Iovance Biotherapeutics, Inc. -1.89 USD 42.857%
IQVIA Holdings Inc. 7.39 USD 114.614%
Mettler-Toledo International Inc. 36.10 USD 102.992%
Myriad Genetics, Inc. -1.39 USD 22.302%
Neurocrine Biosciences, Inc. 2.56 USD 142.188%
Sarepta Therapeutics, Inc. -5.80 USD 81.379%
Supernus Pharmaceuticals, Inc. 0.02 USD 4581.328%
Verastem, Inc. -3.96 USD 72.727%
Walgreens Boots Alliance, Inc. -10.01 USD 89.211%
Waters Corporation 10.87 USD 109.936%
Biogen Inc. 8.02 USD 113.466%
Nektar Therapeutics -1.45 USD 25.517%
Perrigo Company plc -0.09 USD -1050.16%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 89.525%
Heron Therapeutics, Inc. -0.80 USD -35.0%
Unity Biotechnology, Inc. -2.70 USD 60.0%
BioMarin Pharmaceutical Inc. 0.89 USD 221.348%
Sangamo Therapeutics, Inc. -1.48 USD 27.027%
Adicet Bio, Inc. -3.31 USD 67.372%
Aclaris Therapeutics, Inc. -1.27 USD 14.961%
Regeneron Pharmaceuticals, Inc. 37.05 USD 102.915%
Esperion Therapeutics, Inc. -2.03 USD 46.798%
FibroGen, Inc. -2.92 USD 63.014%
Agilent Technologies, Inc. 4.22 USD 125.592%
OPKO Health, Inc. -0.25 USD -332.0%
Homology Medicines, Inc. -7.41 USD 85.425%
Geron Corporation -0.32 USD -237.5%
Alnylam Pharmaceuticals, Inc. -3.52 USD 69.318%
Exelixis, Inc. 0.65 USD 266.154%
Viking Therapeutics, Inc. -0.91 USD -18.681%
Anavex Life Sciences Corp. -0.60 USD -80.0%
Intellia Therapeutics, Inc. -5.42 USD 80.074%
Zoetis Inc. 5.08 USD 121.26%
Axsome Therapeutics, Inc. -5.27 USD 79.507%
Abeona Therapeutics Inc. -2.53 USD 57.312%
Vertex Pharmaceuticals Incorporated 14.05 USD 107.687%
Kala Pharmaceuticals, Inc. -17.35 USD 93.775%
Ionis Pharmaceuticals, Inc. -2.56 USD 57.813%
Corcept Therapeutics Incorporated 1.02 USD 205.882%
Halozyme Therapeutics, Inc. 2.13 USD 150.704%
Blueprint Medicines Corporation -8.37 USD 87.097%
Insmed Incorporated -5.34 USD 79.775%
TG Therapeutics, Inc. 0.09 USD 1309.406%
Incyte Corporation 2.67 USD 140.449%
Emergent BioSolutions Inc. -14.85 USD 92.727%